The latest price target for Extendicare (OTCPK:EXETF) was reported by TD Securities on March 11, 2024. The analyst firm set a price target for $7.50 expecting EXETF to rise to within 12 months (a possible 5.01% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for Extendicare (OTCPK:EXETF) was provided by TD Securities, and Extendicare maintained their hold rating.

There is no last upgrade for Extendicare

There is no last downgrade for Extendicare.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Extendicare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Extendicare was filed on March 11, 2024 so you should expect the next rating to be made available sometime around March 11, 2025.

While ratings are subjective and will change, the latest Extendicare (EXETF) rating was a maintained with a price target of $7.00 to $7.50. The current price Extendicare (EXETF) is trading at is $7.14, which is within the analyst’s predicted range.